Mark Sheptoff Financial Planning, LLC Novavax Inc Transaction History
Mark Sheptoff Financial Planning, LLC
- $197 Million
- Q3 2025
A detailed history of Mark Sheptoff Financial Planning, LLC transactions in Novavax Inc stock. As of the latest transaction made, Mark Sheptoff Financial Planning, LLC holds 300 shares of NVAX stock, worth $2,091. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300Holding current value
$2,091% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVAX
# of Institutions
311Shares Held
95.7MCall Options Held
5.7MPut Options Held
9.06M-
Vanguard Group Inc Valley Forge, PA15.2MShares$106 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$82.6 Million0.0% of portfolio
-
Shah Capital Management11.8MShares$82.3 Million45.37% of portfolio
-
State Street Corp Boston, MA7.2MShares$50.2 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.27MShares$29.8 Million0.02% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $545M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...